학술논문

Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status
Document Type
article
Source
Cell Host & Microbe. 30(3)
Subject
Vaccine Related
Immunization
Biodefense
Lung
Infectious Diseases
Pneumonia & Influenza
Prevention
Emerging Infectious Diseases
3.4 Vaccines
Prevention of disease and conditions
and promotion of well-being
Infection
Good Health and Well Being
Antibodies
Viral
COVID-19
COVID-19 Vaccines
Epitopes
T-Lymphocyte
Humans
SARS-CoV-2
Spike Glycoprotein
Coronavirus
Vaccination
T cells
breakthrough infection
epitope
immunodiagnostic tool
vaccination
viruses
Microbiology
Medical Microbiology
Immunology
Language
Abstract
Both SARS-CoV-2 infections and COVID-19 vaccines elicit memory T cell responses. Here, we report the development of 2 pools of experimentally defined SARS-CoV-2 T cell epitopes that, in combination with spike, were used to discriminate 4 groups of subjects with different SARS-CoV-2 infection and COVID-19 vaccine status. The overall T cell-based classification accuracy was 89.2% and 88.5% in the experimental and validation cohorts. This scheme was applicable to different mRNA vaccines and different lengths of time post infection/post vaccination and yielded increased accuracy when compared to serological readouts. T cell responses from breakthrough infections were also studied and effectively segregated from vaccine responses, with a combined performance of 86.6% across all 239 subjects from the 5 groups. We anticipate that a T cell-based immunodiagnostic scheme to classify subjects based on their vaccination and natural infection history will be an important tool for longitudinal monitoring of vaccinations and for establishing SARS-CoV-2 correlates of protection.